Insider transactions

Richard J Berman

CIK 1111620 · Chief Executive Officer · last filed 2025-01-07

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$2.11M
Companies
17
Total Filings
128
Lifetime Open-Market Net
-$6.79M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

CYRX price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
305 COLLEGE ROAD EAST
PRINCETON, NJ 08540
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BIVI Director 4,064 $1.44 $5.9K -$198.7K 8 2025-01-07
Celularity Inc (CELUW) Delisted Director 67,416 $0.00 $128 $0 2 2025-01-06
CNTX Director — $0.24 — $0 3 2024-06-14
CYRX Director 112,845 $18.34 $2.07M -$4.70M 31 2024-05-21
COMSovereign Holding Corp. (COMSW) Delisted Director — $0.01 — $0 1 2021-04-06
Ontrak, Inc. (OTRKP) Delisted Director — $0.37 — $0 1 2021-02-16
Ayala Pharmaceuticals, Inc. (ADXS) Delisted Director — $0.60 — $0 3 2020-05-05
Ayala Pharmaceuticals, Inc. (ADXSW) Delisted Director 55,669 — — $0 3 2018-06-27
LISATA THERAPEUTICS, INC. (CLBS) Delisted Director 478 $6.40 $3.1K $0 3 2017-01-31
Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted Director 66,430 — — -$343.2K 6 2016-08-10
LISATA THERAPEUTICS, INC. (NBS) Delisted Director 38,766 — — -$186.7K 9 2015-06-04
LISATA THERAPEUTICS, INC. (NBS.WS) Delisted Director 185,306 — — -$270.1K 8 2012-07-03
EASYLINK SERVICES INTERNATIONAL CORP (ESIC) Delisted Director 82,006 — — -$1.06M 7 2011-08-02
NEXM Director 22,656 $1.40 $31.7K -$30.9K 12 2010-04-01
LISATA THERAPEUTICS, INC. (NBS.U) Delisted Director 137,728 — — $0 1 2007-10-01
EASYLINK SERVICES INTERNATIONAL CORP (ICCA) Delisted Director — — — $0 1 2007-01-09
DYADIC INTERNATIONAL INC (DIL) Delisted Director — — — $0 1 2007-01-08

Recent Filings · Page 10 of 13

128 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2011-08-02 EASYLINK SERVICES INTERNATIONAL CORP (ESIC) Delisted Grant (A) +28,774 $0 EDGAR
2011-07-19 EASYLINK SERVICES INTERNATIONAL CORP (ESIC) Delisted Sell (S) −39,474 -$228.7K EDGAR
2011-07-19 EASYLINK SERVICES INTERNATIONAL CORP (ESIC) Delisted Mixed +39,474 -$342.1K EDGAR
2011-07-18 EASYLINK SERVICES INTERNATIONAL CORP (ESIC) Delisted Mixed — -$23.0K EDGAR
2010-10-18 — Grant (A) — $0
2010-08-20 LISATA THERAPEUTICS, INC. (NBS.WS) Delisted Sell (S) −80,000 -$120.0K EDGAR
2010-07-02 — Grant (A) +1,308 $6.0K
2010-04-01 NEXM Grant (A) +32,680 $10.0K EDGAR
2010-03-11 NEXM Sell (S) −61,873 -$30.9K EDGAR
2010-02-25 EASYLINK SERVICES INTERNATIONAL CORP (ESIC) Delisted Grant (A) +4,831 $0 EDGAR
Showing 91–100 of 128
Page 10 of 13
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.